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OBJECTIVE— To compare the metabolic effects of fructose in healthy male and female
subjects.
RESEARCHDESIGNANDMETHODS— Fasting metabolic profile and hepatic insulin
sensitivity were assessed by means of a hyperglycemic clamp in 16 healthy young male and
female subjects after a 6-day fructose overfeeding.
RESULTS— Fructose overfeeding increased fasting triglyceride concentrations by 71 vs. 16%
in male vs. female subjects, respectively (P  0.05). Endogenous glucose production was in-
creased by 12%, alanine aminotransferase concentration was increased by 38%, and fasting
insulin concentrations were increased by 14% after fructose overfeeding in male subjects (all P
0.05) but were not significantly altered in female subjects. Fasting plasma free fatty acids and
lipid oxidation were inhibited by fructose in male but not in female subjects.
CONCLUSIONS— Short-term fructose overfeeding produces hypertriglyceridemia and he-
patic insulin resistance in men, but these effects are markedly blunted in healthy young women.
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H igh fructose intake has been associ-ated with adverse metabolic effects(1). Few studies have addressed
whether the metabolic effects of fructose
are sex dependent, however. In rats, sev-
eral reports show that fructose has more
pronounced adverse metabolic effects in
males than in females (2,3); similarly, in
humans, only men showed fructose-
induced hypertriglyceridemia (4,5). The
aim of this study was to further assess
whether the effects of short-term fructose
overfeeding on fasting lipid metabolism
and insulin sensitivity differ between men
and women.
RESEARCH DESIGN AND
METHODS— Healthy, nonsmoking,
Caucasian male (n  8, mean  SD age
22.5  0.93 years, BMI 22.5  1.4, and
percent fat mass 14.2 3.1%) and female
(n  8, age 22.9  0.62 years, BMI
21.0  1.4, and percent fat mass 24.6 
2.5%) volunteers took part in the study.
All subjects were in good health, and
none were taking medications (except
oral contraception for women).
Each subject was studied on two oc-
casions. On one occasion (control test),
they were placed on a balanced, isoener-
getic diet (100% energy requirements:
15% proteins, 35% lipids, 40% starch,
and 10% mono- and disaccharides) for 6
days. On the other occasion, they were
placed on the same isoenergetic diet sup-
plemented with 3.5 g fructose  kg fat-free
mass1  day1 for 6 days (130% energy
requirements: 11% proteins, 26% lipids,
30% starch, 8% glucose and disacchar-
ides, and 25% fructose). The two dietary
conditions were applied in a randomized
order with a 4-week washout period. On
the seventh day, subjects underwent a
metabolic assessment including basal
hormone and substrate concentrations,
fasting endogenous glucose, and glucose
metabolism during a two-step hypergly-
cemic clamp (6). Women who were not
on oral contraceptive (n  2) were stud-
ied during the first 10 days of their men-
strual cycle.
Statistical analysis
Data are expressed as means  SEM.
Comparisons between control diet and
fructose supplementation were per-
formed using the paired Wilcoxon’s
signed-rank test. Comparison between
male and female subjects was done using
Wilcoxon’s rank-sum test.
RESULTS— Basal metabolic parame-
ters were comparable in female and male
subjects, except for a higher glucose pro-
duction (P  0.05) and a trend toward
higher plasma insulin (P 0.12), triglyc-
erides (P 0.06), and-hydroxybutyrate
(P  0.17) in female subjects.
Body weight was increased by 1.1%
in male and 0.7% in female subjects after
fructose supplementation. In male sub-
jects, fructose supplementation caused
significant (P 0.05) increases in fasting
glucose (5% increase), insulin (14% in-
crease), triglyceride (71% increase), ala-
nine aminotransferase (38% increase),
and lactate (44% increase) and decreases
in free fatty acids (43%), -hydroxybu-
tyrate (87%), and glucagon (10%). It
also significantly (P  0.05) increased
fasting endogenous glucose production
(12% increase) and basal carbohydrate
oxidation (43% increase) and decreased
basal lipid oxidation (48%) (Table 1).
The metabolic effects of fructose
supplementation were markedly atten-
uated in female subjects, in whom it
caused only significant increases in fast-
ing glucose (4%) and triglyceride (16%)
and decreases in -hydroxybutyrate
(55%) and glucagon (9%) while all
other parameters showed no significant
changes (Table 1). The increment in en-
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dogenous glucose production and
plasma triglyceride and the decrement
in -hydroxybutyrate were all signifi-
cantly lower in female than in male sub-
jects (P  0.05).
During the clamp, endogenous glu-
cose production during the first step was
significantly higher (13%, P 0.05) after
fructose supplementation in male sub-
jects but not in female subjects. The first-
phase insulin secretion and the plasma
insulin concentration at the first plateau
of glycemia were not altered after fructose
overfeeding in male and female subjects.
During the second plateau of glycemia,
plasma insulin concentration was in-
creased by 26% (P  0.05) after fructose
supplementation in male but not female
subjects (Table 1).
CONCLUSIONS— The female sub-
jects participating in this study had, at
baseline, slightly higher plasma triglycer-
ides and endogenous glucose production
than the male subjects, suggesting a lower
metabolic fitness. In spite of this, they
showed a markedly blunted increase in
plasma triglycerides in response to fruc-
tose. Several explanations can be pro-
posed for this lesser effect of fructose:
first, the effect of fructose on metabolism
may be modulated by sex hormones. In
support of this hypothesis, studies done
in rats showed that intact, but not oopho-
rectomized, female rats were protected
against the deleterious metabolic effects
of fructose (3). It was also reported that
fructose increased plasma triglyceride in
postmenopausal but not premenopausal
women (7). Fatty acid synthase gene ex-
pression is also lower in hepatocytes of
female or estrogen-treated male rats
than in untreated male rats, which sug-
gests that fructose-induced hepatic de
novo lipogenesis may be attenuated in
women (8). Second, women have a
larger fat mass than men at comparable
BMI and may have a more efficient re-
moval of triglyceride-rich particles from
circulation (9).
This study was done in small groups
of healthy male and female subjects with
different baseline metabolic characteris-
tics and needs to be replicated by larger-
scale studies. It nonetheless calls for
attention to sex-related factors in future
studies. It is possible that the vascular risk
associated with high fructose intake is re-
duced in young women due to their lower
plasma triglycerides. In addition to this
differential effect on plasma triglycerides,
fructose inhibited lipolysis and lipid oxi-
dation in male subjects, presumably sec-
ondary to a slight increase in insulin
secretion (10), but failed to do so in fe-
male subjects. Furthermore, it increased
basal glucose production and fasting in-
sulin concentrations, which indicates he-
patic insulin resistance, in male subjects,
whereas these effects were totally abol-
ished in female subjects. It also failed to
increase alanine aminotransferase in fe-
male subjects as it did in male subjects.
Given the importance attributed to lipo-
toxicity and to ectopic fat deposition in
skeletal muscle and the liver (11) in the
development of insulin resistance, it can
be speculated that an enhanced triglycer-
ide removal in subcutaneous adipose
tissue and a lesser inhibition of fat oxida-
tion may offer some protection against
fructose-induced insulin resistance in
young women by reducing fructose-
induced lipotoxicity.
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